Sort by:

Company news

Successful completion of BJS Biotechnologies projects at UCL

  File 1 – Successful completion of BJS Biotechnologies projects at UCL

read more

Congratulations

BJS Biotechnologies would like to congratulate our Product Specialist, Charlotte Fenner, for graduating from Imperial College London with a Masters in Applied Bioscience and Biotechnology. The ceremony was held at the Royal Albert Hall last week and was a great celebration to  mark this achievement.

read more

Introducing SEPSIS-xxpress

SEPSIS-xxpress is BJS Biotechnologies’ rapid POC (point of care) sepsis testing system in development as part of a London-based consortium. The new system combines BJS’s experience in sample preparation, automation and real-time PCR with Brunel University London’s microfluidic engineering skills, while St Georges, University of London, will run clinical trials. With an estimated 25 million annual […]

read more
pills

Notes on sepsis

Sepsis (blood poisoning) is a life threatening illness reflecting the body’s release of inflammatory cytokines in response to the presence of bacterial and/or fungal pathogens in the bloodstream. Sepsis is the leading cause of death in US hospitals. Mortality from sepsis increases at a rate of 8% for every hour that a patient is not receiving […]

read more
xxpress PCR team at Downing Street

xxpress PCR gets involved in Britain is GREAT

The xxpress PCR team has visited Number 10 Downing Street in London to launch BJS Biotechnologies‘ work with the UK Trade & Investment‘s Britain is GREAT campaign. Britain is Great is a UK government drive to showcase the very best of what Britain has to offer. “We are proud to be working with the GREAT […]

read more

xxpress takes centre stage in a keynote online seminar

xxpress®, BJS Biotechnologies’ ultra-high speed qPCR system, has been featured in an online seminar PCR Past, Present and Future as a PCR technology of the future by Stephen Bustin, Professor of Allied Health and Medicine at Anglia Ruskin University. Following his involvement with trials of xxpress, Bustin commented: “We are heading towards faster (systems) and […]

read more
Biotechnica

BJS launching xxpress in Germany at Biotechnica 2013

BJS Biotechnologies will be launching its xxpress® qPCR thermal cycler in Germany at BIOTECHNICA 2013 (Hannover, 8-10 October 2013). Designed to be quick, accurate and easy to use, xxpress could save you money as well as time in qPCR by using smaller volumes of reagents than other machines, as well as completely interchangeable sample plates. […]

read more
Richard Lewis and Maria Thorpe

BJS Biotechnologies presents postgraduate biosciences award

In an informal ceremony last week Richard Lewis, BJS Biotechnologies’ chairman, presented Maria Thorpe, MSc, with the BJS Biotechnologies Award for Best Postgraduate student in Biosciences at Brunel University. Maria Thorpe achieved an MSc with Distinction in Molecular Medicine and Cancer Research. “BJS Biotechnologies is once again delighted to be sponsoring this prestigious prize. It […]

read more

A grand day out: Launching xxpress at the Coronation Festival

It hardly seems possible but a fortnight has gone by already since the successful launch of BJS Biotechnologies’ xxpress, the world’s fastest and most thermally accurate real-time qPCR thermal cycler, at the glorious Coronation Festival at Buckingham Palace. “Buckingham Palace was a sensational place to launch xxpress and the positive response from our biotechnology guests […]

read more

XXpressPCR launches at the Coronation Festival this week

We are excited to say that this week BJS Group of Companies, including BJS Technologies (the manufacturers of xxpress®), will be taking part in the Coronation Festival at Buckingham Palace, where we will be launching our revolutionary qPCR DNA testing machine. BJS Biotechnology was spun out of the BJS Group of Companies back in 2011 […]

read more